Ultra-Processed Foods and T2D: The Evidence Has Reached a Tipping Point

Written by Clare Koning, RN, PhD May 2026 7 min read

Key Highlights

✅ High-quality prospective evidence now links ultra-processed food consumption directly to type 2 diabetes (T2D) risk

✅ Every 10% increase in UPF intake is associated with a 12% to 14% higher risk of developing T2D

✅ The relationship is dose-dependent and holds after adjusting for obesity, diet quality, and lifestyle factors

✅ Not all processed foods are equal: the type of UPF matters as much as the quantity

✅ The NOVA classification system is becoming a practical clinical tool, not just a research framework

The term "ultra-processed food" has spent years hovering at the edges of nutrition science, carrying the air of something that sounds alarming but lacks the hard evidence to back it up. That characterisation is no longer accurate. In the past three years, a convergence of large-scale prospective cohort studies and high-quality meta-analyses has moved the science from suggestive to substantial, and the implications for type 2 diabetes prevention and management are difficult to overstate.

This is not a fringe position. High-quality meta-evidence now supports a direct, dose-dependent relationship between ultra-processed food (UPF) consumption and the risk of developing type 2 diabetes, independent of obesity, physical inactivity, and overall diet quality. For healthcare providers still reaching for the traditional "eat less sugar and saturated fat" framework, and for patients navigating a food environment dominated by products engineered to displace whole foods, this evidence demands a more specific and more urgent conversation.

What Is an Ultra-Processed Food?

The term comes from the NOVA food classification system, a framework developed by researchers at the University of São Paulo that categorizes foods not by nutrient content but by the degree and purpose of processing. NOVA divides foods into four groups: unprocessed or minimally processed foods (fresh vegetables, meat, eggs); processed culinary ingredients (oils, flour, salt); processed foods (canned vegetables, cheese, cured meats); and ultra-processed foods.

Image taken from: https://www.mdpi.com/2218-273X/15/2/307

Ultra-processed foods are industrial formulations made mostly or entirely from substances extracted from foods, often chemically modified, combined with additives designed to enhance palatability, shelf life, colour, and texture. They include: soft drinks, packaged snack foods, reconstituted meat products, instant noodles, breakfast cereals with added sugars, flavoured yogurts with thickeners, and most ready-to-eat meals. What defines them is not a single "bad" ingredient but the totality of their industrial fabrication and the additives used to make them hyper-palatable and highly convenient.

In Canada, as in most high-income countries, UPFs make up a large portion of total caloric intake. Among 33,795 U.S. children and adolescents, ultra-processed food consumption increased to 67% of total energy intake between 1999 and 2018.

This is not a marginal dietary pattern. It is the dominant one.

What the Evidence Actually Shows

The research base has developed considerably in recent years, and the most rigorous findings now represent high-quality evidence by standard epidemiological criteria.

A meta-analysis published in Diabetes Care, drawing on three large US prospective cohorts including the Nurses' Health Study I and II and the Health Professionals Follow-up Study (5,187,678 person-years; n = 19,503 T2D cases), found that people in the highest quintile of UPF consumption had the higher risk of developing T2D compared to those in the lowest quintile, after adjusting for multiple confounders.

Every 10% increase in the proportion of your diet that comes from ultra-processed foods is associated with a 12% to 14% higher risk of developing type 2 diabetes. The relationship is linear and dose-dependent.

A dose-response meta-analysis published in Diabetes Metabolism Journal in 2025, synthesizing 12 prospective cohort studies, corroborated these findings. Each 10% increase in UPF intake was associated with a 14% higher T2D risk, with a potential threshold effect emerging at around 300 grams per day. Importantly, the association was maintained after adjusting for BMI, meaning the pathway between UPF consumption and diabetes is not simply explained by weight gain, though weight gain is one mechanism.

A separate updated systematic review and meta-analysis including 14 prospective cohort studies and over 692,000 participants found a pooled hazard ratio of 1.24 (95% CI 1.14 to 1.34) for the highest versus lowest UPF consumption categories, consistent with a clinically meaningful elevation in risk. This means that UPF consumption results in a greater risk of T2D and can contribute to its complications.

The Mechanisms: Why UPFs Damage Metabolic Health

The biological plausibility of this association is supported by multiple converging pathways. UPFs contribute to diabetes risk through both their nutrient composition and through mechanisms entirely distinct from macronutrient content.

On the nutrient side, UPFs are typically high in refined carbohydrates and added sugars that produce rapid postprandial glucose and insulin spikes, and low in dietary fibre, which slows glucose absorption and supports gut microbiome diversity. Both of these profiles directly promote insulin resistance over time.

But the UPF story extends beyond nutrients. Research published in Biomolecules in 2025 has identified specific additives in UPFs, including emulsifiers, artificial sweeteners, acrylamide formed during high-heat processing, and bisphenol-A leached from packaging, as independently implicated in disrupting the gut microbiome, promoting low-grade systemic inflammation, and impairing insulin signalling. This suggests that two people consuming similar quantities of sugar and saturated fat will have meaningfully different metabolic outcomes depending on whether those macronutrients arrive in whole foods or ultra-processed vehicles.

The gut microbiome dimension is particularly relevant. As reviewed earlier in our blog series, a Westernized dietary pattern dominated by UPFs reduces microbial diversity and promotes the proliferation of pro-inflammatory taxa, while depleting the short-chain fatty acid-producing bacteria associated with improved insulin sensitivity.

Not All Processed Foods Are Equal

One of the most practically useful findings from this body of research is the evidence on heterogeneity within the UPF category itself.

The large US cohort study was able to disaggregate UPF subgroups, and the results are instructive. Refined breads, artificially and sugar-sweetened beverages, sauces and condiments, animal-based processed products, and ready-to-eat mixed dishes were all associated with higher T2D risk. However, some UPF subgroups, including dark and whole-grain packaged breads, plain yogurt and dairy-based products, and some fruit-based products, were associated with lower risk, even though they meet the technical NOVA definition of ultra-processed.

This is an important nuance for clinical dietary guidance. The goal is not to create patient anxiety around every food with an ingredient list, but to help people identify the specific categories, sweetened beverages, refined grain products, reconstituted meats, and heavily emulsified savoury snacks, that carry the highest metabolic cost.

Reducing ultra-processed food consumption does not require a perfect diet. It requires identifying the highest-risk categories and making targeted, sustainable substitutions.

Clinical Implication

When reviewing dietary patterns with patients who have T2D or prediabetes, moving beyond the traditional sugar-and-fat framework toward a conversation about food processing level and UPF category is now supported by high-quality evidence. Asking patients about their consumption of sweetened beverages, packaged savoury snacks, and ready-to-eat meals is a specific and evidence-aligned line of clinical enquiry.

The Food Environment Problem

It would be incomplete to address UPF consumption as though it were purely a matter of individual choice. The food environments in which most Canadians live are designed, deliberately and commercially, to maximize the consumption of ultra-processed products. They are cheaper per calorie than whole foods, more heavily marketed, more convenient, and engineered through flavour science to override satiety signals.

The downstream consequence is that people with lower incomes and in food-insecure settings tend to have higher UPF consumption, not because of poor decision-making, but because of constrained access to affordable whole foods. This means UPF exposure is not equally distributed, and any clinical conversation about reducing UPF intake must be sensitive to the social and economic context of each patient's life. The evidence on UPF and T2D risk adds urgency to policy arguments for food labelling reform, front-of-pack warning labels, and pricing interventions that make whole foods more accessible.

What This Means for People with T2D

For people already living with type 2 diabetes, the evidence on UPFs reinforces priorities that may already be familiar, but with a more specific target. Rather than the general instruction to "eat less processed food," the evidence points toward a handful of high-impact substitutions: replacing sweetened beverages with water, sparkling water, or unsweetened drinks; swapping refined bread products for whole grain versions; choosing minimally processed proteins over reconstituted meat products; and reducing reliance on ready-to-eat and packaged convenience meals in favour of simple whole food preparations.

These are not dramatic transformations. They are targeted, evidence-based shifts that reduce UPF exposure at the highest-risk end of the spectrum.

For practical guidance on healthy eating with T2D, visit the T2D Network's Healthy Eating page.

Join us for weekly insights